NCT02840955View on ClinicalTrials.gov

The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Atopic Dermatitis
Interventions
DEVICE

Staphefekt SA.100

OTHER

Placebo

Trial Locations (1)

Unknown

Erasmus Medical Centre, Rotterdam

Sponsors

Collaborators (1)

Micreos
All Listed Sponsors
collaborator

Micreos

UNKNOWN

collaborator

TNO

OTHER

collaborator

Regional Public Health Laboratory Kennemerland

UNKNOWN

lead

Erasmus Medical Center

OTHER